QNRXNasdaqPharmaceutical Preparations
Quoin Pharmaceuticals Ltd.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$3.98+0.08 (+2.05%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Quoin Pharmaceuticals statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Quoin Pharmaceuticals | Industry median |
|---|---|---|
| Market Cap | $7.99M | $166.30M |
| Enterprise Value | -$2.81M | $88.19M |
| PB Ratio | 2.03 | 2.03 |
| P/TBV Ratio | 2.22 | 2.29 |
Income (trailing twelve months)
| Measure | Quoin Pharmaceuticals | Industry median |
|---|---|---|
| Net Income | -$18.67M | -$22.46M |
Returns
| Measure | Quoin Pharmaceuticals | Industry median |
|---|---|---|
| Return on Equity (ROE) | -575.7% | -53.2% |
| Return on Assets (ROA) | -178.8% | -40.9% |
Balance sheet
| Measure | Quoin Pharmaceuticals | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $10.80M | $61.43M |
| Net Cash (Debt) | $10.80M | $15.35M |
| Net Cash Per Share | $0.15 | $0.66 |
| Equity (Book Value) | $3.93M | $49.09M |
| Book Value Per Share | $0.06 | $1.37 |
| Tangible Book Value | $3.60M | $23.52M |
| Working Capital | $5.02M | $76.81M |
Financial position
| Measure | Quoin Pharmaceuticals | Industry median |
|---|---|---|
| Current Ratio | 1.76 | 3.34 |
| Quick Ratio | 1.63 | 2.44 |
Cash flow (trailing twelve months)
| Measure | Quoin Pharmaceuticals | Industry median |
|---|---|---|
| Operating Cash Flow | -$15.27M | -$12.35M |
Efficiency
| Measure | Quoin Pharmaceuticals | Industry median |
|---|---|---|
| Profits Per Employee | -$4.67M | -$703.34K |
| Employee Count | 4 | 74 |
Dividends and yields
| Measure | Quoin Pharmaceuticals | Industry median |
|---|---|---|
| Earnings Yield | -233.5% | -23.3% |
Shares
| Measure | Quoin Pharmaceuticals | Industry median |
|---|---|---|
| Shares Outstanding | 70,294,600 | 58,127,000 |
| Shares Change (QoQ) | 2.41% | 0.54% |
| Float | 68,157,800 | 49,136,700 |
| Shares Held by Insiders | 3.04% | 11.6% |
| Shares Held by Institutions | 1.85% | 59.4% |
Scores
| Measure | Quoin Pharmaceuticals | Industry median |
|---|---|---|
| Altman Z-Score | -8.41 | -0.22 |
Calculated by StockData from Quoin Pharmaceuticals's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.